𝐒𝐭𝐞𝐦 𝐂𝐞𝐥𝐥 𝐓𝐫𝐚𝐧𝐬𝐩𝐥𝐚𝐧𝐭 𝐒𝐡𝐨𝐰𝐬 𝐏𝐫𝐨𝐦𝐢𝐬𝐞 𝐢𝐧 𝐑𝐞𝐬𝐭𝐨𝐫𝐢𝐧𝐠 𝐕𝐢𝐬𝐢𝐨𝐧 𝐟𝐨𝐫 𝐂𝐨𝐫𝐧𝐞𝐚𝐥 𝐃𝐚𝐦𝐚𝐠𝐞 𝐏𝐚𝐭𝐢𝐞𝐧𝐭𝐬.
👁 A recent study published in The Lancet has shown promising results for stem cell therapy in treating patients with corneal damage. Researchers at Osaka University Hospital used corneal epithelial cell sheets derived from human induced pluripotent stem cells (iPSCs) to treat four patients with limbal stem-cell deficiency (LSCD).
😀 The results were encouraging: all patients showed improved vision and reduced corneal opacity after a year, with no significant adverse effects. This breakthrough paves the way for further research, including larger clinical trials to assess the potential of iPSCs as a treatment for LSCD.